S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)|
|CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results as a Treatment for HIV-Related Kaposi's Sarcoma (KS)|
|CytRx Announces FDA's Removal of Partial Clinical Hold for Aldoxorubicin Clinical Trials Permitting Immediate Enrollment of New Patients|
|CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium|
|CytRx Announces Publication of Preclinical Glioblastoma Data in Neoplasia|
|CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials|
|CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical Trials|
|CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference|
|CytRx Reports 2014 Third Quarter Financial Results|
Click above to view more mutual fund data and stats for cx5n - CytRx Corp.